E-Mail
IMAGE: Lundquist Investigator Dr. Dong Chang and his colleagues study on critically ill patients and ICU treatments was published in JAMA Internal Medicine. The study - Evaluation of Time-Limited Trials Among. view more
Credit: Courtesy of The Lundquist Institute
LOS ANGELES (April 13, 2021) The Lundquist Institute (TLI) Investigator Dong W. Chang, MD, and his colleagues study on critically ill patients and ICU treatments was published in
JAMA Internal Medicine. The study - Evaluation of Time-Limited Trials Among Critically Ill Patients with Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments - found that training physicians to communicate with family members of critically ill patients using a structured approach, which promotes shared decision-making, improved the quality of family meetings. This intervention was associated with reductions in invasive ICU treatments that prolonged suffering without benefit for patients and their
BridgeBio Pharma, Inc and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
BridgeBio Pharma, Inc and Roswell Park Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Cancers
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.